Treatment decisions for patients with brain arteriovenous
|
|
- Giles Logan
- 5 years ago
- Views:
Transcription
1 Risk of Endovascular Treatment of Brain Arteriovenous Malformations A. Hartmann, MD; J. Pile-Spellman, MD; C. Stapf, MD; R.R. Sciacca, EngScD; A. Faulstich, MS; J.P. Mohr, MD; H.C. Schumacher, MD; H. Mast, MD Background and Purpose Independently assessed data on frequency, severity, and determinants of neurological deficits after endovascular treatment of brain arteriovenous malformations (AVMs) are scarce. Methods From the prospective Columbia AVM Study Project, 233 consecutive patients with brain AVM receiving 1 endovascular treatments were analyzed. Neurological impairment was assessed by a neurologist using the Scale before and after completed endovascular therapy. Multivariate logistic regression models were used to identify demographic, clinical, and morphological predictors of treatment-related neurological deficits. The analysis included the components used in the Spetzler-Martin risk score for AVM surgery (AVM size, venous drainage pattern, and eloquence of AVM location). Results The 233 patients were treated with 545 endovascular procedures. Mean follow-up time was 9.6 months (SD, 18.1 months). Two hundred patients (86%) experienced no change in neurological status after treatment, and 33 patients (14%) showed treatment-related neurological deficits. Of the latter, 5 (2%) had persistent disabling deficits ( score 2), and 2 (1%) died. Increasing patient age [odds ratio (OR), 1.04; 95% confidence interval (CI), 1.01 to 1.08], number of embolizations (OR, 1.41; 95% CI, 1.16 to 1.70), and absence of a pretreatment neurological deficit (OR, 4.55; 95% CI, 1.03 to 20.0) were associated with new neurological deficits. None of the morphological AVM characteristics tested predicted treatment complications. Conclusions From independent neurological assessment and prospective data collection, our findings suggest a low rate of disabling treatment complications in this center for endovascular brain AVM treatment. Risk predictors for endovascular treatment differ from those for AVM surgery. (Stroke. 2002;33: ) Key Words: arteriovenous malformations embolization, therapeutic outcome Treatment decisions for patients with brain arteriovenous malformations (AVMs) are based on natural-course risk estimates weighed against outcome data from invasive intervention. At present, both remain incompletely defined. 1 4 Endovascular treatment of brain AVMs aims to obliterate or reduce the size of the malformation. It is frequently followed by surgical AVM removal or radiotherapy. 5 7 As with AVM surgery, determinants of complications from endovascular treatment are not well described Originally designed to predict outcome from AVM surgery, the Spetzler-Martin 12 grading system is often used to categorize brain AVMs before endovascular therapy as well, but its applicability to this treatment modality remains unsettled. Studies on AVM embolization outcome using independent neurological data collection are scarce. The purpose of this single-center study was to prospectively and independently assess treatment outcome after embolization therapy of brain AVMs with modern embolization techniques and to analyze determinants of treatment-related neurological deficits. Patients and Methods The New York (NY) AVM Databank is an ongoing, prospective database collecting demographic, clinical, morphological, and treatment data on consecutive patients admitted to the New York Presbyterian Hospital with brain AVM proven by brain imaging and conventional cerebral angiography. Other types of intracranial fistulas (eg, dural AV fistulas, vein of Galen type malformations) are not included. Study patients are drawn from the New York metropolitan area and from distant referral sites. Further details on the design and methods of the data set have been described in prior publications. 3,5,13 As a general rule, the study patients were treated with the goal of complete AVM obliteration or removal by endovascular occlusion alone or in combination with subsequent surgery or radiosurgery. The 233 consecutive patients with brain AVMs receiving 1 endovascular treatments between 1991 and 1998 were analyzed. Subsequent treatment was surgical in 130 patients (56%) and Received January 7, 2002; final revision received April 1, 2002; accepted April 8, From the Stroke Center, Neurological Institute, New York Presbyterian Hospital, New York (A.H., C.S., R.R.S., J.P.M., H.C.S., H.M.); Department of Interventional Neuroradiology, Columbia University, College of Physicians and Surgeons, New York, NY (A.H., J.P.-S.); Stroke Unit, Department of Neurology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Berlin, Germany (A.H., C.S.); and Schlaganfallzentrum Halle, Stroke Unit, Berufsgenossenschaftliche Kliniken, Bergmannstrost, Halle, Germany (A.F., H.C.S., H.M.). Correspondence to Andreas Hartmann, MD, Stroke Unit, Neurologische Klinik, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 1200 Berlin, Germany. ahart@zedat.fu-berlin.de 2002 American Heart Association, Inc. Stroke is available at DOI: /01.STR B2 1816
2 Hartmann et al Brain AVM Embolization Outcome 1817 radiosurgical in 23 patients (10%). Neurological deficit, disability, and impairment were independently assessed by a study neurologist. Functional neurological status was documented before embolization and after each endovascular treatment session until completion of endovascular therapy by use of the modified Scale. 14,15 Any worsening of the patient s preembolization score was coded as a new neurological deficit. This included worsening of patients with a preexisting neurological deficit. New neurological deficits were classified as disabling when scores were 3. For patients with baseline scores of 2, any score increase was classified as disabling. Superselective microcatheter cannulation of arteries feeding the AVM and injection of N-butyl cyanoacrylate were used to occlude the fistulae. The technique remained the same throughout the study period. One hundred patients were embolized with 1 session each; 133 patients were treated multiple times (mean, 2.4 procedures; SD, 2.8 procedures; range, 1 to 11 procedures). Univariate statistics ( 2 or, when appropriate, Fisher s exact test, t test) and forward stepwise multiple logistic regression procedures were used to describe the effect of demographic factors, mode of initial AVM presentation, preembolization neurological status, and morphological parameters on embolization outcome. To test the validity of the Spetzler-Martin grading system, the univariate and multivariate (backward stepwise multiple logistic regression procedures) analyses included the total score from the grading system and its individual components: AVM size (score of 1 small size, with a maximum diameter of 3 cm; 2 medium size, with a diameter of 3 to 6 cm; 3 large size, with a diameter of 6 cm), venous drainage (score of 1 AVM with any drainage into the internal, deep cerebral venous system), and location of the AVM (score of 1 for AVM in functionally important, so-called eloquent brain regions: the sensorimotor, language, and visual cortex; hypothalamus and thalamus; internal capsule; brainstem; cerebellar peduncles; and deep cerebellar nuclei). Results Demographic, clinical, and morphological information on the study sample is given in Table 1. By baseline score, 89% of the patients had no functionally relevant neurological deficit ( score 0 or 1), and 94% were nondisabled ( score 2; Table 2). A total of 33 patients [14%; 95% confidence interval (CI), 9 to 19] showed treatment-related new neurological deficits, including 5 with disabling deficits (2%; 95% CI, 0 to 4) and 2 (1%; 95% CI, 0 to 2) who died. By scale, 200 patients (86%; 95% CI, 81 to 91) experienced no change in neurological status after treatment, and 92% were nondisabled (Table 2). Of the 200 patients who experienced no change in functional status, 41 (18%) had a preexisting neurological deficit that remained unchanged after endovascular therapy. After the embolization session that caused a new neurological deficit, 19 of 33 patients (58%) later underwent surgery, 9 (27%) continued with the embolization therapy, 3 (9%) had achieved complete AVM obliteration at the time of the complication, and 2 (6%) died without receiving further invasive treatment. The 2 patients who died suffered parenchymal hemorrhage, both with ventricular extension. The 5 patients with disabling complications had treatment-induced ischemic strokes (2 middle cerebral artery, 1 anterior choroidal artery, 1 anterior inferior cerebellar artery, and 1 superior cerebellar artery infarct). Clinical information on these patients is provided in Table 3. Patients with a treatment-related new neurological deficit had significantly more embolizations and were more frequently neurologically normal at baseline (Table 4). TABLE 1. Demographic, Clinical, and Morphological Characteristics of 233 Patients With Brain AVM Undergoing Embolization Therapy Mean SD age (range), y (9 72) Female sex, n (%) 124 (53) Initial presentation, n (%) Intracranial hemorrhage 93 (40) Seizure 74 (32) Headache 40 (17) Focal deficit 11 (5) Other/asymptomatic 15 (6) Embolizations, n 545 Mean SD follow-up time, mo Patients undergoing surgery after endovascular treatment, n (%) 126 (54) Maximum (mean SD) AVM diameter (range), mm (5 80) AVMs with deep arterial feeders,* n (%) 42 (18) AVMs with choroidal arterial feeders, n (%) 49 (21) Border-zone AVM location, n (%) 124 (53) Patients with concurrent arterial aneurysms, n (%) 41 (18) Spetzler-Martin criteria, n (%) Small AVM (diameter 3 cm) 46 (20) Medium AVM (3 6 cm) 179 (77) Large AVM ( 6 cm) 8 (3) Deep venous drainage, n (%) 128 (55) Eloquent location, n (%) 159 (68) Spetzler-Martin score, n (%) 1 12 (5) 2 43 (19) (43) 4 68 (29) 5 8 (3) *Defined as penetrating branches of the major intracranial arteries of the circle of Willis. Defined as arterial supply by branches of 2 of the major arteries of circle of Willis. Includes aneurysms on feeding arteries and intranidal aneurysms. Includes location in the sensorimotor, visual, or language cortex; basal ganglia; internal capsule; brainstem; cerebellar peduncles; and deep cerebellar nuclei. In the multivariate analyses, increasing age, number of embolizations, and normal neurological status at baseline were significantly associated with treatment complications (Table 5). For all other variables shown in Table 4, no significant association was found. Neither the overall score of the Spetzler-Martin grading system (P 0.163) nor its 3 components tested separately predicted treatment outcome (Table 6). Restricting the univariate analysis to disabling neurological deficits or death, we found significant associations for increasing age [P 0.021; odds ratio (OR), 5.59; 95% CI, 1.11 to 28.14], initial presentation with hemorrhage (P 0.017; OR, 9.59; 95% CI, 1.14 to 80.98), small AVM size (P 0.005; OR, 5.30; 95% CI, 1.13 to 24.95), and presence of deep arterial feeders (P 0.021; OR, 6.60; 95% CI, 1.42 to 30.68). Of the 7 patients (43%) with disabling complications
3 1818 Stroke July 2002 TABLE 2. Scores of 233 Patients Undergoing Endovascular Brain AVM Treatment Before and After Completed Embolization Therapy Baseline Posttreatment Score* n % n % * 0 no symptoms at all; 1 able to carry out all usual duties and activities; 2 unable to carry out all previous activities but able to look after own affairs; 3 requiring some help but able to walk without assistance; 4 unable to walk without assistance and unable to attend to bodily needs; 5 bedridden, incontinent, and requiring constant nursing care and attention; and 6 death. or fatal outcome, 3 had small AVMs (maximum diameter 30 mm according to Spetzler-Martin criteria). Of these, 1 was located in the cerebellar hemisphere, another in the brainstem, and the last in the basal ganglia. The low number of end points precluded meaningful multivariate models for disabling deficits or death. Additional partial correlation analyses showed that younger patients carried larger AVMs and were treated more often than older patients. TABLE 3. Patient Sex Discussion Outcome after AVM embolization therapy has improved over the last decade. The rate of treatment-related permanent neurological deficits and death culled from the literature ranges from 4% to 18%, 5 depending on the material used to obliterate the malformation, the means of delivering the occlusive agent, and patient selection. 9,10,16 19 Our data suggest a further reduction in treatment-related disabling morbidity and mortality. However, despite the low number of disabling complications, the overall rate of neurological deficits was 14%. Prospective and independent evaluation by a neurologist may reveal a larger number of less severe complications, as has been shown in carotid surgery outcome studies. 20,21 Consequently, the detection rate of mild neurological deficits may have been higher in our study than in others, but the low rate of disabling complications is accredited. The 2 fatal complications in our series were brain hemorrhages. There was no intranidal aneurysm in either patient, and the flow-related aneurysm found in 1 patient was not considered a likely source of the hemorrhage. Also, no venous occlusion that may have led to outflow obstruction with subsequent hemorrhage was noted during or after the embolization. Autopsy was not performed in either patient; therefore, the cause of hemorrhage remains undetermined. Some authors have suggested that most complications from embolization occur on the venous side of the AVM, 6 but in our series, all nonhemorrhagic disabling events were due to arterial occlusions. In our findings, the number of embolizations and a normal neurological status before treatment were significant predictors of treatment-related neurological deficits. The increasing risk with additional embolizations is not surprising, given the greater exposure to potential complications with each treatment. The complication risk from embolization therefore is likely to be higher in patients whose treatment plan includes multiple embolization sessions. Normal neurological examination at baseline as a predictor of treatment-related deficits may reflect the higher likelihood of patients with no preexisting focal neurological signs to reveal new symptoms, especially a better detection rate for mild deficits. A similar effect has been observed in surgical AVM treatment, 8 lending support to our observation in this study. Clinical Status of Patients With Brain AVMs and Endovascular Treatment-Related Disabling Deficits or Death Age, y Clinical Presentation AVM Location 1 M 20 Hemorrhage Left frontotemporo-parietal Deep Arterial Feeders Aneurysms Venous Drainage Embolizations, n Preembolization Postembolization Clinical Syndrome None None Deep AChA infarct with moderate hemiparesis 2 M 53 Hemorrhage Left occipital MCA Flow related Deep superficial Massive ventricular hemorrhage; patient died 3 F 50 Seizure Left fronto-temporal MCA None Superficial MCA infarct with aphasia and moderate hemiparesis 4 M 62 Hemorrhage Left frontal ACA None Deep superficial MCA infarct with moderate hemiparesis; myocardial infarction 5 M 52 Hemorrhage Brainstem BA None Deep superficial AICA infarct with dysarthria and ataxia 6 M 30 Hemorrhage Left basal ganglia PChA None Deep Thalamic and ventricular hemorrhage; patient died 7 M 67 Hemorrhage Left cerebellar AICA Flow related Superficial SCA infarct with ataxia AChA indicates anterior choroidal artery; MCA, middle cerebral artery; ACA, anterior cerebral artery; BA, basilar artery; AICA, anterior inferior cerebellar artery; PChA, posterior choroidal artery; and SCA, superior cerebellar artery.
4 Hartmann et al Brain AVM Embolization Outcome 1819 TABLE 4. Association of Demographic and Morphological Parameters With Neurological Complications Related to Endovascular AVM Treatment in 233 Patients Postembolization Outcome Any Deficit No Deficit Parameter (n 33) (n 200) OR (95% CI) P Age (mean SD), y ( ) Female sex (n 124), n (%) 14 (42) 110 (55) 0.60 ( ) Embolizations (mean SD), n ( ) 0.005* No neurological deficit at baseline (n 185), n (%) 31 (94) 154 (77) 4.63 ( ) 0.026* Mode of initial presentation, n (%) Hemorrhage (n 93) 14 (42) 79 (40) 1.13 ( ) Seizure (n 74) 9 (27) 65 (33) 0.78 ( ) Headache (n 40) 7 (21) 33 (17) 1.36 ( ) Neurological deficit (n 11) 1 (3) 10 (5) 0.59 ( ) Other/asymptomatic (n 15) 2 (6) 13 (7) 0.93 ( ) Maximum AVM diameter (mean SD), mm ( ) Infratentorial AVM location (n 24), n (%) 2 (6) 22 (11) 0.52 ( ) Border-zone location (n 124), n (%) 17 (52) 107 (54) 0.92 ( ) Deep arterial feeders (n 42), n (%) 9 (27) 33 (17) 1.89 ( ) Choroidal arterial feeders (n 49), n (%) 9 (27) 40 (20) 1.50 ( ) Concurrent aneurysms, n (%) Any (n 43) 6 (18) 37 (19) 0.98 ( ) Flow related (n 33) 5 (15) 28 (14) 1.10 ( ) Intranidal (n 10) 1 (3) 9 (5) 0.66 ( ) Spetzler-Martin criteria, n (%) Small AVM size ( 3 cm) 5 (15) 42 (21) 0.67 ( ) Medium AVM size (3 6 cm) 27 (82) 151 (76) 1.46 ( ) Large AVM size ( 6 cm) 1 (3) 7 (4) 0.86 ( ) Deep venous drainage, n (%) 22 (67) 107 (54) 1.74 ( ) Eloquent AVM location# 24 (73) 136 (68) 1.26 ( ) Percentages refer to column total. *P Tested for significance with 2 statistics or Fisher s exact test when appropriate unless otherwise indicated. Tested for significance with t test statistics. Defined as arterial supply by branches of 2 of the major arteries of the circle of Willis. Defined as penetrating branches of the major intracranial arteries of the circle of Willis. Includes aneurysms related to shunt flow and intranidal aneurysms. #Includes location in the visual, language, and sensorimotor cortex; basal ganglia; internal capsule; brainstem cerebellar peduncles; and deep cerebellar nuclei. The reason for the higher treatment risk in older patients despite their smaller AVMs and less frequent embolizations than younger patients is less obvious. General vascular disease may be more prevalent in older patients, although TABLE 5. Multivariate Logistic Regression Model Testing the Association of Demographic and Morphological Parameters With Neurological Deficits Related to Endovascular AVM Treatment in 233 Patients Parameter OR 95% CI P Age Number of embolizations* No neurological deficit at baseline *Defined as sessions of endovascular treatment regardless of the number of vessels occluded at each session. none of the patients treated showed evidence of atherosclerosis. Moreover, the effect of age was marginal (OR, 1.04; lower limit of the CI, 1.01); the mean age difference between TABLE 6. Multivariate Logistic Regression Model Testing the Association of Spetzler-Martin Score and Its Components With Neurological Deficits Related to Endovascular AVM Treatment in 233 Patients Parameter OR 95% CI P Spetzler-Martin score Spetzler-Martin components AVM size Deep venous drainage Eloquent AVM location
5 1820 Stroke July 2002 the patients who developed new deficits and those who remained unchanged was small (40 14 versus years); and changes in hemostasis 22 or nutritional problems encountered in surgery on elderly patients 23 did not apply to our patients. The low rate of disabling complications or death in our study precludes a meaningful multivariate analysis of their predictors. Trends from our univariate analyses suggest clinical and morphological predictors of poor embolization outcome that were also identified in natural-course risk estimates, ie, hemorrhage at initial presentation and small AVM size. 3 The association of deep arterial feeders with the failure to achieve complete obliteration of the malformation was previously suggested. 24 However, the CIs of our relative risk analyses were large, and studies on more patients are needed to better define predictors of complications. In our analysis, neither the total score of the Spetzler- Martin grading system nor any of its 3 components predicted treatment complications. The system was originally designed and validated to predict surgical treatment outcome. 12,25 Although found helpful by many authors, our results suggest that morphological variables other than those in the grading system need to be defined to predict outcome from endovascular therapy. It remains unproven whether endovascular AVM treatment affects the complication risk from subsequent surgery or radiosurgery. Ideally, embolization facilitates other modes of treatment, and a prior analysis showed no deleterious effect of endovascular therapy on AVM surgery outcome. 8 In staged AVM treatment, complications from all treatment forms need to be considered in determinations of the total complication rate for complete AVM removal. Acknowledgment This work was supported in part by NIH grant RO1 NS (principal investigator, W.L. Young, MD). References 1. Fisher WS. Therapy of AVMs: a decision analysis. Clin Neurosurg. 1995;42: Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990;73: Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile- Spellman J, Hacein-Bey L, Duong H, Stein BM, Mohr JP. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350: Duong DH, Young WL, Vang MC, Sciacca RR, Mast H, Koennecke HC, Hartmann A, Joshi S, Mohr JP, Pile-Spellman J. Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke. 1998;29: Arteriovenous Malformation Study Group. Arteriovenous malformations of the brain in adults. N Engl J Med. 1999;340: Berenstein A, Lasjaunias P. Endovascular treatment of cerebral lesions. In: Berenstein A, Lasjaunias P, eds. Surgical Neuroangiography. New York, NY: Springer Verlag; Jafar JJ, Davis AJ, Berenstein A, Choi IS, Kupersmith MJ. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg. 1993;78: Hartmann A, Stapf C, Hofmeister C, Mohr JP, Sciacca RR, Stein BM, Faulstich A, Mast H. Determinants of neurological outcome after surgery for brain arteriovenous malformation. Stroke. 2000;31: Gobin YP, Laurent A, Merienne L, Schlienger M, Aymard A, Houdart E, Casasco A, Lefkopoulos D, George B, Merland JJ. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg. 1996;85: Vinuela F, Dion JE, Duckwiler G, Martin NA, Lylyk P, Fox A, Pelz D, Drake CG, Girvin JJ, Debrun G. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg. 1991;75: Mast H, Koennecke HC, Meisel J, Osipov A, Hartmann A, Lasjaunias P, Pile-Spellman J, Hacein-Bey L, Young WL, Mohr JP. Zur Therapie zerebraler arteriovenöser Malformationen. Nervenarzt. 1998;69: Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65: Hartmann A, Mast H, Mohr JP, Koennecke HC, Osipov A, Pile-Spellman J, Duong DH, Young WL. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke. 1998;29: van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19: de Haan R, Limburg M, Bossuyt P, van der MJ, Aaronson N. The clinical meaning of handicap grades after stroke. Stroke. 1995;26: Debrun G, Vinuela F, Fox A, Drake CG. Embolization of cerebral arteriovenous malformations with bucrylate. J Neurosurg. 1982;56: Purdy PD, Samson D, Batjer HH, Risser RC. Preoperative embolization of cerebral arteriovenous malformations with polyvinyl alcohol particles: experience in 51 adults. AJNR Am J Neuroradiol. 1990;11: Wikholm G, Lundqvist C, Svendsen P. Transarterial embolization of cerebral arteriovenous malformations: improvement of results with experience. AJNR Am J Neuroradiol. 1995;16: Paulsen RD, Steinberg GK, Norbash AM, Marcellus ML, Marks MP. Embolization of basal ganglia and thalamic arteriovenous malformations. Neurosurgery. 1999;44: ; discussion Rothwell PM, Slattery J, Warlow CP. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke. 1996;27: Hartmann A, Hupp T, Koch HC, Dollinger P, Stapf C, Schmidt R, Hofmeister C, Thompson JL, Marx P, Mast H. Prospective study on the complication rate of carotid surgery. Cerebrovasc Dis. 1999;9: Boldt J, Huttner I, Suttner S, Kumle B, Piper SN, Berchthold G. Changes of haemostasis in patients undergoing major abdominal surgery: is there a difference between elderly and younger patients? Br J Anaesth. 2001; 87: Bozzetti F. Surgery in the elderly: the role of nutritional support. Clin Nutr. 2001;20: Wikholm G, Lundqvist C, Svendsen P. Embolization of cerebral arteriovenous malformations, part I: technique, morphology, and complications. Neurosurgery. 1996;39: ; discussion Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery. 1994;34:2 6; discussion Deruty R, Pelissou-Guyotat I, Amat D, Mottolese C, Bascoulergue Y, Turjman F, Gerard JP. Complications after multidisciplinary treatment of cerebral arteriovenous malformations. Acta Neurochir (Wien). 1996;138: Steinberg GK, Lane B, Marks MP. Endovascular therapy for intracranial vascular lesions. West J Med. 1990;153: Henkes H, Nahser HC, Berg-Dammer E, Weber W, Lange S, Kuhne D. Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res. 1998;20:
I ntracranial haemorrhage is the main cause of morbidity and
294 PAPER Concurrent arterial aneurysms in brain arteriovenous malformations with haemorrhagic presentation C Stapf, J P Mohr, J Pile-Spellman, R R Sciacca, A Hartmann, H C Schumacher, H Mast... See end
More informationThe treatment of brain arteriovenous malformations. Neurologic Complications of Arteriovenous Malformation Embolization Using Liquid Embolic Agents
ORIGINAL RESEARCH M.V. Jayaraman M.L. Marcellus S. Hamilton H.M. Do D. Campbell S.D. Chang G.K. Steinberg M.P. Marks Neurologic Complications of Arteriovenous Malformation Embolization Using Liquid Embolic
More informationBrain Arteriovenous Malformations Endovascular Therapy and Associated Therapeutic Protocols Jorge Guedes Cabral de Campos
Endovascular Therapy and Associated Therapeutic Protocols Jorge Guedes Cabral de Campos Neuroradiology Department Hospital de Santa Maria University of Lisbon CEREBRAL AVM CLINICAL / EPIDEMIOLOGY Brain
More informationSupratentorial cerebral arteriovenous malformations : a clinical analysis
Original article: Supratentorial cerebral arteriovenous malformations : a clinical analysis Dr. Rajneesh Gour 1, Dr. S. N. Ghosh 2, Dr. Sumit Deb 3 1Dept.Of Surgery,Chirayu Medical College & Research Centre,
More informationProposal of Classification of Aneurysms Coexisting with Avm and Possible Treatment Strategies
DOI: 10.5137/1019-5149.JTN.8600-13.1 Received: 23.05.2013 / Accepted: 18.07.2013 Original Investigation Proposal of Classification of Aneurysms Coexisting with Avm and Possible Treatment Strategies Xianli
More informationTransarterial Embolization of Cerebral Arteriovenous Malformations: Improvement of Results with Experience
Transarterial Embolization of Cerebral Arteriovenous Malformations: Improvement of Results with Experience Gunnar Wikholm, Christer Lundqvist, and Paul Svendsen PURPOSE: To present the treatment outcome
More informationDiagnosis and Management of AVM in the Pregnant Patient
Diagnosis and Management of AVM in the Pregnant Patient Wade Cooper, D.O. University of Michigan Assistant Professor Departments of Neurology & Anesthesiology Disclosures Wade Cooper - None Developmental
More informationCerebral haemorrhage from a remote varix in the venous outflow of an arteriovenous malformation treated successfully by embolisation
The British Journal of Radiology, 83 (2010), e129 e134 CASE REPORT Cerebral haemorrhage from a remote varix in the venous outflow of an arteriovenous malformation treated successfully by embolisation 1
More informationMethods. Treatment options for intracranial arteriovenous malformations
AJNR Am J Neuroradiol 25:1139 1143, August 2004 Complete Obliteration of Intracranial Arteriovenous Malformation with Endovascular Cyanoacrylate Embolization: Initial Success and Rate of Permanent Cure
More informationNeurosurgical decision making in structural lesions causing stroke. Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery)
Neurosurgical decision making in structural lesions causing stroke Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery) Subarachnoid Hemorrhage Every year, an estimated 30,000 people in the United States experience
More informationAlt h o u g h infratentorial AVMs comprise only
Neurosurg Focus 26 (5):E12, 2009 Posterior fossa arteriovenous malformations Om a r M. Arn a o u t, B.A., 1 Br a d l e y A. Gr o s s, M.D., 2 Ch r i s t o p h e r S. Ed d l e m a n, M.D., Ph.D., 1 Be r
More informationBrain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage
Cronicon OPEN ACCESS EC PAEDIATRICS Case Report Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage Dimitrios Panagopoulos* Neurosurgical Department, University
More informationThe outcome of treatment for arteriovenous malformations of the brain: A five-year retrospective series from the Philippines
Neurology Asia 2006; 11 : 91 96 ORIGINAL ARTICLES The outcome of treatment for arteriovenous malformations of the brain: A five-year retrospective series from the Philippines Roland Mark M GIGATARAS MD,
More informationEndovascular Treatment of Cerebral Arteriovenous Malformations. Bs. Nguyễn Ngọc Pi Doanh- Bs Đặng Ngọc Dũng Khoa Ngoại Thần Kinh
Endovascular Treatment of Cerebral Arteriovenous Malformations Bs. Nguyễn Ngọc Pi Doanh- Bs Đặng Ngọc Dũng Khoa Ngoại Thần Kinh Stroke Vascular Malformations of the Brain Epidemiology: - Incidence: 0.1%,
More informationBlood Supply. Allen Chung, class of 2013
Blood Supply Allen Chung, class of 2013 Objectives Understand the importance of the cerebral circulation. Understand stroke and the types of vascular problems that cause it. Understand ischemic penumbra
More informationTransarterial Embolisation of Cerebral Arteriovenous Malformations
Transarterial Embolisation of Cerebral Arteriovenous Malformations How Few Can You Do? G. WIKHOLM, C. LUNDQVIST*, P. SVENDSEN Section of Interventional Neuroradiology, Department of Radiology, * Department
More informationModern treatment of brain arteriovenous malformation
ORIGINAL RESEARCH W.J. van Rooij M. Sluzewski G.N. Beute Brain AVM Embolization with Onyx BACKGROUND AND PURPOSE: To report the initial experience by using a new liquid embolic agent (Onyx) for embolization
More informationVascular Malformations of the Brain: A Review of Imaging Features and Risks
Vascular Malformations of the Brain: A Review of Imaging Features and Risks Comprehensive Neuroradiology: Best Practices October 27-30, 2016 Sudhakar R. Satti, MD Associate Director Neurointerventional
More informationRadiographic and statistical analysis of Brain Arteriovenous Malformations.
Radiographic and statistical analysis of Brain Arteriovenous Malformations. Poster No.: C-0996 Congress: ECR 2017 Type: Educational Exhibit Authors: C. E. Rodriguez 1, A. Lopez Moreno 1, D. Sánchez Paré
More informationAngioarchitecture of Brain Arteriovenous Malformations and the Risk of Bleeding: An Analysis of Patients in Northeastern Malaysia
Brief Communication Angioarchitecture of Brain Arteriovenous Malformations and the Risk of Bleeding: An Analysis of Patients in Northeastern Malaysia Shibani KanDai 1, Mohd Shafie abdullah 1, Nyi Nyi naing
More informationEMBOLIZATION OF ARTERIOVENOUS FISTULA AFTER RADIOSURGERY FOR MULTIPLE CEREBRAL ARTERIOVENOUS MALFORMATIONS
Arteriovenous fistula after radiosurgery for multiple CAVM EMBOLIZATION OF ARTERIOVENOUS FISTULA AFTER RADIOSURGERY FOR MULTIPLE CEREBRAL ARTERIOVENOUS MALFORMATIONS Chao-Bao Luo, Wan-Yuo Guo, Michael
More informationEndovascular treatment of intracranial arteriovenous malformations
Endovascular treatment of intracranial arteriovenous malformations Tomaž Šeruga Department of Radiology, Teaching Hospital Maribor, Maribor, Slovenia Background. The aim of the study was the introduction
More informationVascular Malformations
Vascular Malformations LTC Robert Shih Chief of Neuroradiology Walter Reed Medical Center Special thanks to LTC Alice Smith (retired) Disclosures: None. This presentation reflects the personal views of
More informationLife after ARUBA: Management of Unruptured Brain Arteriovenous Malformations (AVMs)
Life after ARUBA: Management of Unruptured Brain Arteriovenous Malformations (AVMs) Eric L. Zager, MD University of Pennsylvania Department of Neurosurgery No Disclosures Brain AVMs Incidence ~1 in 100,000
More informationOBJECTIVES. At the end of the lecture, students should be able to: List the cerebral arteries.
DR JAMILA EL MEDANY OBJECTIVES At the end of the lecture, students should be able to: List the cerebral arteries. Describe the cerebral arterial supply regarding the origin, distribution and branches.
More informationThe New York Islands AVM Study is an ongoing, prospective,
Research Report The New York Islands AVM Study Design, Study Progress, and Initial Results C. Stapf, MD; H. Mast, MD; R.R. Sciacca, EngScD; A. Berenstein, MD; P.K. Nelson, MD; Y.P. Gobin, MD; J. Pile-Spellman,
More informationNidus reduction before surgery or radiosurgery, curative
ORIGINAL RESEARCH V. Panagiotopoulos E. Gizewski S. Asgari J. Regel M. Forsting I. Wanke Embolization of Intracranial Arteriovenous Malformations with Ethylene-Vinyl Alcohol Copolymer (Onyx) BACKGROUND
More informationEndovascular Management of Cerebral Arteriovenous Malformations in Pregnancy: Two Case Reports and a Review of the Literature
Case Report Elmer Press Endovascular Management of Cerebral Arteriovenous Malformations in Pregnancy: Two Case Reports and a Review of the Literature Nitin Agarwal a, Grant Schalet b, Manan Shah a, Peter
More informationUntangling Cerebral Dural Arteriovenous Fistulas
Untangling Cerebral Dural Arteriovenous Fistulas Bradley A. Gross, MD Assistant Professor, Dept of Neurosurgery, University of Pittsburgh September 2017 davfs Definition Clinical Presentation Natural History
More informationPrinciples Arteries & Veins of the CNS LO14
Principles Arteries & Veins of the CNS LO14 14. Identify (on cadaver specimens, models and diagrams) and name the principal arteries and veins of the CNS: Why is it important to understand blood supply
More information[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]
2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available
More informationClinical Commissioning Policy: Arteriovenous Malformations. December Reference : NHSCB/D5/4
Clinical Commissioning Policy: Arteriovenous Malformations December 2012 Reference : NHSCB/D5/4 NHS Commissioning Board Clinical Commissioning Policy: Arteriovenous Malformations First published: December
More informationIntracranial dural arteriovenous fistulas (DAVFs) with retrograde
ORIGINAL RESEARCH W.J. van Rooij M. Sluzewski G.N. Beute Dural Arteriovenous Fistulas with Cortical Venous Drainage: Incidence, Clinical Presentation, and Treatment BACKGROUND AND PURPOSE: Our purpose
More informationMicrosurgical Resection of Incompletely Obliterated Intracranial Arteriovenous Malformations Following Stereotactic Radiosurgery
II-2. Selection of Treatment Microsurgical Resection of Incompletely Obliterated Intracranial Arteriovenous Malformations Following Stereotactic Radiosurgery Steven D. CHANG*, Gary K. STEINBERG*, Richard
More informationSpontaneous occlusion of a cerebral arteriovenous malformation after subtotal endovascular embolisation
206 Chiriac et al Spontaneous occlusion of a cerebral arteriovenous malformation Spontaneous occlusion of a cerebral arteriovenous malformation after subtotal endovascular embolisation A. Chiriac, N. Dobrin*,
More informationT HE hemodynamics and embolization of cerebral
J Neurosurg 79:383-389, 1993 Evaluation of pressure changes in feeding arteries during embolization of intracerebral arteriovenous malformations TAKASHI HANDA, M.D., MAKOTO NEGORO, M.D., SHIGERU MIYACHI,
More informationEstimating the Risks of Adverse Radiation Effects After Gamma Knife Radiosurgery for Arteriovenous Malformations
Estimating the Risks of Adverse Radiation Effects After Gamma Knife Radiosurgery for Arteriovenous Malformations Hideyuki Kano, MD, PhD; John C. Flickinger, MD; Daniel Tonetti, MD; Alan Hsu, MD; Huai-che
More informationMichael K. Morgan, MD, 1 Markus K. Hermann Wiedmann, MD, 1 Marcus A. Stoodley, PhD, 1 and Gillian Z. Heller, PhD 2
CLINICAL ARTICLE J Neurosurg 127:1105 1116, 2017 Microsurgery for Spetzler-Ponce Class A and B arteriovenous malformations utilizing an outcome score adopted from Gamma Knife radiosurgery: a prospective
More informationCT and MR Imaging in Young Stroke Patients
CT and MR Imaging in Young Stroke Patients Ashfaq A. Razzaq,Behram A. Khan,Shahid Baig ( Department of Neurology, Aga Khan University Hospital, Karachi. ) Abstract Pages with reference to book, From 66
More informationDECISION MAKING IN AVM TREATMENT STRATEGY TREATMENT BOARD SYSTEM AT TOHOKU UNIVERSITY
Kitakanto Med. J. (S1) : 79-84, 1998 79 DECISION MAKING IN AVM TREATMENT STRATEGY TREATMENT BOARD SYSTEM AT TOHOKU UNIVERSITY Takashi Yoshimoto, Hidefumi Jokura Department of Neurosurgery, Tohoku University
More informationSpetzler-Martin Grade III arteriovenous malformations. Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations.
See the corresponding editorial in this issue, pp 955 958. J Neurosurg 120:959 969, 2014 AANS, 2014 Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations Clinical article Dale Ding, M.D.,
More informationPartial targeted embolisation of brain arteriovenous malformations
Eur Radiol (2010) 20: 2723 2731 DOI 10.1007/s00330-010-1834-3 NEURO Timo Krings Franz-Josef Hans Sasikhan Geibprasert Karel Terbrugge Partial targeted embolisation of brain arteriovenous malformations
More informationSpontaneous Obliteration of Pial Arteriovenous Malformations: A Review of 27 Cases
AJNR Am J Neuroradiol :, March 00 Spontaneous Obliteration of Pial Arteriovenous Malformations: A Review of ases Maneesh. Patel, Timothy J. Hodgson, Andras A. Kemeny, and David M. Forster BAKGROUND AND
More informationPublished February 7, 2013 as /ajnr.A3409
Published February 7, 2013 as 10.3174/ajnr.A3409 ORIGINAL RESEARCH INTERVENTIONAL Combined Treatment of Brain AVMs with Use of Onyx Embolization Followed by Radiosurgery L. Pierot, K. Kadziolka, F. Litré,
More informationA.J. Hauer Intracranial dural arteriovenous fistulae
A.J. Hauer 27-06-2018 Intracranial dural arteriovenous fistulae Dural arteriovenous fistulae (davfs) epidemiology Pathological anastomoses (within the dural leaflets) between meningeal arteries and dural
More informationMedical Neuroscience Tutorial Notes
Medical Neuroscience Tutorial Notes Blood Supply to the Brain MAP TO NEUROSCIENCE CORE CONCEPTS 1 NCC1. The brain is the body's most complex organ. LEARNING OBJECTIVES After study of the assigned learning
More information7/5/2016. Neonatal high-output cardiac failure. Case 1 POSTNATAL STRATEGIES FOR CEREBRAL ATERIOVENOUS MALFORMATIONS
John Deveikis, M.D. POSTNATAL STRATEGIES FOR CEREBRAL ATERIOVENOUS MALFORMATIONS JULY, 2016 Neonatal high-output cardiac failure Tachypnea, tachycardia, hypotension, failure to thrive When congenital heart
More informationMASSIVE EPISTAXIS IN A NEONATE: A SYMPTOM OF VEIN OF GALEN MALFORMATION!
CASE REPORT MASSIVE EPISTAXIS IN A NEONATE: A SYMPTOM OF VEIN OF GALEN MALFORMATION! Shagufta Wahab 1, Rizwan Ahmad Khan 2, Manjari Thapa Manger 3 1. Radiodiagnosis, Aligarh Muslim University, Aligarh,
More informationANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS
ANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS Dr. Maitri P Gandhi 1, Dr. Chandni P Shah 2 1 Junior resident, Gujarat Cancer & Research
More informationOnyx in Brain Arteriovenous Malformation Embolisation
Original Article Submitted: 4 Jan 2016 Accepted: 9 May 2016 Online: 30 June 2016 Onyx in Brain Arteriovenous Malformation Embolisation Hilwati Hashim 1, A Sobri Muda 2, Aida Abdul Aziz 3, Zuhanis Abdul
More informationDOES TREATMENT WITH N-BUTYL CYANOACRYLATE EMBOLIZATION PROTECT AGAINST HEMORRHAGE IN CEREBRAL ARTERIOVENOUS MALFORMATIONS?
Arq Neuropsiquiatr 2005;63(1):34-39 DOES TREATMENT WITH N-BUTYL CYANOACRYLATE EMBOLIZATION PROTECT AGAINST HEMORRHAGE IN CEREBRAL ARTERIOVENOUS MALFORMATIONS? Eduardo Floriani Raupp 1, Jefferson Fernandes
More informationLong-term control of large pontine arteriovenous malformation using gamma knife therapy: a review with illustrative case
Long-term control of large pontine arteriovenous malformation using gamma knife therapy: a review with illustrative case Martin M. Mortazavi 1, Daxa Patel 1, Christoph J. Griessenauer 1, R. Shane Tubbs
More informationCoiling of Very Large or Giant Cerebral Aneurysms: Long-Term Clinical and Serial Angiographic Results
AJNR Am J Neuroradiol 24:257 262, February 2003 Coiling of Very Large or Giant Cerebral Aneurysms: Long-Term Clinical and Serial Angiographic Results Menno Sluzewski, Tomas Menovsky, Willem Jan van Rooij,
More informationEssentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II
14. Ischemia and Infarction II Lacunar infarcts are small deep parenchymal lesions involving the basal ganglia, internal capsule, thalamus, and brainstem. The vascular supply of these areas includes the
More informationPediatric Neurointervention: Vein of Galen Malformations
Pediatric Neurointervention: Vein of Galen Malformations Johanna T. Fifi, M.D. Assistant Professor of Neurology, Neurosurgery, and Radiology Icahn School of Medicine at Mount Sinai November 9 th, 2014
More informationDural arteriovenous shunts (DAVSs), also called dural
Natural History of Dural Arteriovenous Shunts Michael Söderman, MD, PhD; Ladislav Pavic, MD, PhD; Göran Edner, MD; Staffan Holmin, MD, PhD; Tommy Andersson, MD, PhD Background and Purpose Dural arteriovenous
More informationComplex dural arteriovenous fistulas. Results of combined endovascular and neurosurgical treatment in 16 patients
J Neurosurg 71:352-358,1989 Complex dural arteriovenous fistulas Results of combined endovascular and neurosurgical treatment in 16 patients STANLEY L. BARNWELL, M.D., PH.D., VAN V. HALBACH, M.D., RANDALL
More informationDOWNLOAD PDF RADIOSURGERY FOR CAVERNOUS MALFORMATIONS IN BASAL GANGLIA, THALAMUS AND BRAINSTEM KIDA, Y
Chapter 1 : Stereotactic radiosurgery for cavernous malformations â Mayo Clinic Most of the lesions were located in the brainstem, followed by the lobar region, cerebellum, thalamus, and basal ganglia
More informationOverview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville
Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Disclosure Statement of Financial Interest Within the
More informationInfluenced by the high morbidity and mortality associated
Hemorrhage Risk of Cerebral Arteriovenous Malformations Before and During the Latency Period After Gamma Knife Radiosurgery Chun-Po Yen, MD; Jason P. Sheehan, MD, PhD; Lucia Schwyzer, MD; David Schlesinger,
More informationPatterns of Brain Arteriovenous Malformation Treatment Prospective, Population-Based Study
Patterns of Brain Arteriovenous Malformation Treatment Prospective, Population-Based Study Janneke van Beijnum, MD; Jo J. Bhattacharya, MSc, FRCR; Carl E. Counsell, MD, MRCP; Vakis Papanastassiou, MD,
More informationTransarterial Occlusion of Solitary Intracerebral Arteriovenous Fistulas
747 Transarterial Occlusion of Solitary Intracerebral Arteriovenous Fistulas Van V. Halbach 1 2 Randall T. Higashida 1 2 Grant B. Hieshima 1 2 Carl W. Hardin 1 Christopher F. Dowd 1 Stanley L. Barnwell
More informationStroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine
Stroke - Intracranial hemorrhage Dr. Amitesh Aggarwal Associate Professor Department of Medicine Etiology and pathogenesis ICH accounts for ~10% of all strokes 30 day mortality - 35 45% Incidence rates
More informationStroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012
Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model
More informationDural Arteriovenous Malformations and Fistulae (DAVM S DAVF S)
Jorge Guedes Campos NEUROIMAGING DEPARTMENT HOSPITAL SANTA MARIA UNIVERSITY OF LISBON PORTUGAL DEFINITION region of arteriovenous shunting confined to a leaflet of packymeninges often adjacent to a major
More informationTreatment of brain AVMs includes different modalities
ORIGINAL RESEARCH W.J. van Rooij S. Jacobs M. Sluzewski B. van der Pol G.N. Beute M.E. Sprengers Curative Embolization of Brain Arteriovenous Malformations with Onyx: Patient Selection, Embolization Technique,
More informationSummary of some of the landmark articles:
Summary of some of the landmark articles: The significance of unruptured intracranial saccular aneurysms: Weibers et al Mayo clinic. 1987 1. 131 patients with 161 aneurysms were followed up at until death,
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationSurgical interventions in intracranial arteriovenous malformations: Indications and outcome analysis in a changing scenario
Original Article Surgical interventions in intracranial arteriovenous malformations: Indications and outcome analysis in a changing scenario Amit Thapa, P. Sarat Chandra, Sumit Sinha, Aditya Gupta, Manmohan
More informationOcclusive hyperemia: a theory for the hemodynamic complications following resection of intracerebral arteriovenous malformations
J Neurosurg 78: 167-175, 1993 Occlusive hyperemia: a theory for the hemodynamic complications following resection of intracerebral arteriovenous malformations NAYEF R. F. AL-RODHAN, M.D., PH.D., THORALF
More informationVASCULAR MALFORMATIONS. Owen Samuels, MD Adam Webb, MD Emory University
VASCULAR MALFORMATIONS Owen Samuels, MD Adam Webb, MD Emory University Introduction Brain and spinal cord vascular malformations can be separated into five main categories: 1) Arteriovenous malformation,
More informationOver the last 25 years the management options for. Stereotactic radiosurgery for arteriovenous malformations of the cerebellum.
J Neurosurg 120:583 590, 2014 AANS, 2014 Stereotactic radiosurgery for arteriovenous malformations of the cerebellum Clinical article Greg Bowden, M.D., M.Sc., 1,3,5 Hideyuki Kano, M.D., Ph.D., 1,3 Daniel
More informationNEURORADIOLOGY DIL part 4
NEURORADIOLOGY DIL part 4 Strokes and infarcts K. Agyem MD, G. Hall MD, D. Palathinkal MD, Alexandre Menard March/April 2015 OVERVIEW Introduction to Neuroimaging - DIL part 1 Basic Brain Anatomy - DIL
More informationAdult Choroidal Vein of Galen Malformation
Adult Choroidal Vein of Galen Malformation Thomas A. Tomsick, Robert J. Ernst, John M. Tew, Thomas G. Brott, and John C. Breneman Summary: We report staged embolization and stereotactic radiation in a
More informationArteriovenous Malformations in the Pediatric Population: Review of the Existing Literature
Published online: September 1, 2016 1664 9737/16/0054 0218$39.50/0 Review Arteriovenous Malformations in the Pediatric Population: Review of the Existing Literature Mohammad El-Ghanem a Tareq Kass-Hout
More informationUnruptured Epileptogenic Brain Arteriovenous Malformations
DOI: 10.5137/1019-5149.JTN.9190-13.1 Received: 31.08.2013 / Accepted: 24.09.2013 Published Online: 16.02.2016 Original Investigation Unruptured Epileptogenic Brain Arteriovenous Malformations Yong SUN
More informationArteriovenous malformations
Seminar Arteriovenous malformations Ian G Fleetwood, Gary K Steinberg Arteriovenous malformations of the brain are congenital vascular lesions that affect 0 01 0 50% of the population, and are generally
More informationDural Arteriovenous Fistula of the Cavernous Sinus Presenting with Progressive Venous Congestion of the Pons and Cerebrum: Report of one case
Dural Arteriovenous Fistula of the Cavernous Sinus Presenting with Progressive Venous Congestion of the Pons and Cerebrum: Report of one case Soo-Bin Yim, M.D., Jong-Sung Kim, M.D., Yang Kwon,M.D.*, Choong-Gon
More informationCerebral Vascular Diseases. Nabila Hamdi MD, PhD
Cerebral Vascular Diseases Nabila Hamdi MD, PhD Outline I. Stroke statistics II. Cerebral circulation III. Clinical symptoms of stroke IV. Pathogenesis of cerebral infarcts (Stroke) 1. Ischemic - Thrombotic
More informationPreembolization Functional Evaluation in Brain Arteriovenous Malformations: The Superselective Amytal Test
Preembolization Functional Evaluation in Brain Arteriovenous Malformations: The Superselective Amytal Test Ronald A. Rauch, 1.2 Fernando Vinuela, 1 Jacques Dion, 1 Gary Duckwiler, 1 Edwin C. Amos, 3 Sheldon
More informationVein of Galen Aneurysms
Interventional Neuroradiology 7 (Suppll): 99103, 2001 Vein of Galen Aneurysms Experience with Eleven Cases. KOIYAA, H. NAKAJIA,. NISHIKAWA, K. YAANAKA, Y. IWAI, T. YASUI, T. ORIKAWA*, S. KITANO*, H. SAKAOTO*,A.
More informationSurgical Neurology International
Surgical Neurology International OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA Original
More informationCerebrovascular Malformations in the Elderly Indications for Treatment
Cerebrovascular Malformations in the Elderly Indications for Treatment Johanna T. Fifi, MD, FAHA, FSVIN Director of Endovascular Ischemic Stroke Assistant Professor of Neurology, Neurosurgery, and Radiology
More informationHigh-Flow, Small-Hole Arteriovenous Fistulas: Treatment with Electrodetachable Coils
High-Flow, Small-Hole Arteriovenous Fistulas: Treatment with Electrodetachable Coils Guido Guglielmi, Fernando Viñuela, Gary Duckwiler, Jacques Dion, and Alfredo Stocker Summary: We present one case of
More informationAcute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT
Ischaemic stroke Characteristics Stroke is the third most common cause of death in the UK, and the leading cause of disability. 80% of strokes are ischaemic Large vessel occlusive atheromatous disease
More informationInterventions in the Management of Acute Stroke. Dr Md Shafiqul Islam Associate Professor Neurosurgery Dhaka Medical College Hospital
Interventions in the Management of Acute Stroke Dr Md Shafiqul Islam Associate Professor Neurosurgery Dhaka Medical College Hospital Acute stroke intervention Number of stroke patients increasing day by
More informationSpontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke
Original Contribution Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke Abstract Introduction: Acute carotid artery occlusion carries
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationEndovascular Treatment of a Fusiform Aneurysm Involving a Premammillary Artery Originating from the Internal Carotid Artery: A Case Report
Journal of Cerebrovascular and Endovascular Neurosurgery pissn 2234-8565, eissn 2287-3139, http://dx.doi.org/10.7461/jcen.2017.19.3.196 Case Report Endovascular Treatment of a Fusiform Aneurysm Involving
More informationLothian Audit of the Treatment of Cerebral Haemorrhage (LATCH)
1. INTRODUCTION Stroke physicians, emergency department doctors, and neurologists are often unsure about which patients they should refer for neurosurgical intervention. Early neurosurgical evacuation
More informationFirst described by Steinheil in 1895, brain arteriovenous. Natural history of brain arteriovenous malformations: a systematic review
Neurosurg Focus 37 (3):E7, 2014 AANS, 2014 Natural history of brain arteriovenous malformations: a systematic review Isaac Josh Abecassis, M.D., 1 David S. Xu, M.D., 2 H. Hunt Batjer, M.D., 3 and Bernard
More informationMoyamoya Syndrome with contra lateral DACA aneurysm: First Case report with review of literature
Romanian Neurosurgery Volume XXXI Number 3 2017 July-September Article Moyamoya Syndrome with contra lateral DACA aneurysm: First Case report with review of literature Ashish Kumar Dwivedi, Pradeep Kumar,
More informationN-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial
AJNR Am J Neuroradiol 23:748 755, May 2002 N-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial The n-bca Trial Investigators
More informationChapter 4 Section 20.1
Surgery Chapter 4 Section 20.1 Issue Date: August 29, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) Copyright: CPT only 2006 American Medical Association (or such other date of publication of CPT). All
More informationSee the corresponding editorial in this issue, pp J Neurosurg 118: , 2013 AANS, 2013
See the corresponding editorial in this issue, pp 967 968. J Neurosurg 118:969 977, 2013 AANS, 2013 The failure of preoperative ethylene-vinyl alcohol copolymer embolization to improve outcomes in arteriovenous
More informationStroke School for Internists Part 1
Stroke School for Internists Part 1 November 4, 2017 Dr. Albert Jin Dr. Gurpreet Jaswal Disclosures I receive a stipend for my role as Medical Director of the Stroke Network of SEO I have no commercial
More informationCurrent treatment modalities for cerebral arteriovenous. Embolization of the choroidal artery in the treatment of cerebral arteriovenous malformations
CLINICAL ARTICLE J Neurosurg 126:1114 1122, 2017 Embolization of the choroidal artery in the treatment of cerebral arteriovenous malformations Alaa Elkordy, MD, 1,5 Hidenori Endo, MD, PhD, 2 Kenichi Sato,
More informationChapter 4 Section 20.1
Surgery Chapter 4 Section 20.1 Issue Date: August 29, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 61000-61626, 61680-62264, 62268-62284, 62290-63048, 63055-64484, 64505-64595,
More informationINSTITUTE OF NEUROSURGERY & DEPARTMENT OF PICU
CEREBRAL BYPASS An Innovative Treatment for Arteritis INSTITUTE OF NEUROSURGERY & DEPARTMENT OF PICU CASE 1 q 1 year old girl -recurrent seizure, right side limb weakness, excessive cry and irritability.
More information